Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type, Clinical Practice, End Use, and Region

Description

List of Tables

The global psychiatric digital biomarkers market size is expected to reach USD 5,543.77 million by 2034, according to a new study by Polaris Market Research. The report "Psychiatric Digital Biomarkers Market Size, Share, Trends, Industry Analysis Report: By Type (Wearable, Mobile-Based Applications, Sensors, and Others), Clinical Practice, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Psychiatric digital biomarkers are objective, quantifiable physiological and behavioral data points collected through digital devices to assess mental health conditions. The psychiatric digital biomarkers market is experiencing significant expansion, driven by advancements in artificial intelligence, wearable health technologies, and mobile-based mental health monitoring. The growing prevalence of psychiatric disorders, including depression, schizophrenia, and anxiety, is fueling psychiatric digital biomarkers market demand, as clinicians and researchers seek data-driven, real-time monitoring tools for accurate diagnosis and treatment personalization. The market growth is further supported by the increasing integration of biosensors in smartwatches, mobile apps, and AI-powered analytics, which enhance remote patient monitoring and clinical decision-making.

The psychiatric digital biomarkers industry trends indicate a shift toward leveraging machine learning algorithms to analyze behavioral patterns, voice biomarkers, and physiological signals, improving predictive accuracy and early intervention capabilities. Additionally, pharmaceutical and biotech companies are incorporating digital biomarkers into clinical trials, optimizing patient recruitment and therapeutic efficacy assessments, thereby driving psychiatric digital biomarkers market expansion. Regulatory advancements and increasing investments in digital health technologies are also encouraging market dynamics as stakeholders focus on ensuring compliance with data privacy and security frameworks.

The psychiatric digital biomarkers market opportunities lie in the development of precision psychiatry, where digital biomarkers are used to tailor treatment strategies based on individual patient data. The increasing adoption of telemedicine and virtual mental health services presents another market opportunity; as healthcare providers integrate digital monitoring solutions into remote care models. As digital biomarkers gain regulatory acceptance and reimbursement frameworks evolve, the market is expected to witness robust growth, with continuous innovation in multimodal data integration and AI-driven mental health analytics shaping the future landscape of psychiatric care.

Psychiatric Digital Biomarkers Market Report Highlights

In terms of type, the wearable segment dominated the psychiatric digital biomarkers market share in 2024, due to the growing integration of advanced biosensors in smartwatches, fitness trackers, and wearable EEG devices for continuous mental health monitoring.

Based on end use, the healthcare companies segment accounted for the largest market share in 2024 due to the increasing adoption of psychiatric digital biomarkers for early diagnosis.

In 2024, North America accounted for the largest share of the psychiatric digital biomarkers market revenue due to the region's advanced healthcare infrastructure.

The Europe market is expected to register the highest CAGR during the forecast period due to government initiatives supporting mental health research.

A few of the global key market players are Biogen; Brainomix; Clario; Empatica Inc.; Huma; IXICO plc; Koneksa Health; PureTech Health PLC; Sonde Health, Inc.; and VivoSense.

Polaris Market Research has segmented the psychiatric digital biomarkers market report on the basis of type, clinical practice, end use, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

Wearable
Mobile-Based Applications
Sensors
Others

By Clinical Practice Outlook (Revenue - USD Million, 2020-2034)

Diagnostic Psychiatric Digital Biomarkers
Monitoring Psychiatric Digital Biomarkers
Predictive and Prognostic Psychiatric Digital Biomarkers
Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

Healthcare Companies
Healthcare Providers
Payers
Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM5446

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Psychiatric Digital Biomarkers Market Insights

4.1. Psychiatric Digital Biomarkers Market - Market Snapshot
4.2. Psychiatric Digital Biomarkers Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Mental Health Disorders
  - 4.2.1.2. Wearable and Mobile Health Technology Advancements
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Data Privacy Concerns
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Psychiatric Digital Biomarkers Market Trends
4.6. Value Chain Analysis

5. Global Psychiatric Digital Biomarkers Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
5.3. Wearable
- 5.3.1. Global Psychiatric Digital Biomarkers Market, by Wearable, by Region, 2020-2034 (USD Million)
5.4. Mobile based Applications
- 5.4.1. Global Psychiatric Digital Biomarkers Market, Mobile based Applications, by Region, 2020-2034 (USD Million)
5.5. Sensors
- 5.5.1. Global Psychiatric Digital Biomarkers Market, by Sensors, by Region, 2020-2034 (USD Million)
5.6. Others
- 5.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Psychiatric Digital Biomarkers Market, by Clinical Practice

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
6.3. Diagnostic Psychiatric Digital Biomarkers
- 6.3.1. Global Psychiatric Digital Biomarkers Market, by Diagnostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
6.4. Monitoring Psychiatric Digital Biomarkers
- 6.4.1. Global Psychiatric Digital Biomarkers Market, by Monitoring Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
6.5. Predictive and Prognostic Psychiatric Digital Biomarkers
- 6.5.1. Global Psychiatric Digital Biomarkers Market, by Predictive and Prognostic Psychiatric Digital Biomarkers, by Region, 2020-2034 (USD Million)
6.6. Others
- 6.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Psychiatric Digital Biomarkers Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
7.3. Healthcare companies
- 7.3.1. Global Psychiatric Digital Biomarkers Market, by Healthcare companies, by Region, 2020-2034 (USD Million)
7.4. Healthcare Providers
- 7.4.1. Global Psychiatric Digital Biomarkers Market, by Healthcare Providers, by Region, 2020-2034 (USD Million)
7.5. Payers
- 7.5.1. Global Psychiatric Digital Biomarkers Market, by Payers, by Region, 2020-2034 (USD Million)
7.6. Others
- 7.6.1. Global Psychiatric Digital Biomarkers Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Psychiatric Digital Biomarkers Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Psychiatric Digital Biomarkers Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Psychiatric Digital Biomarkers Market - North America
- 8.3.1. North America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.3.2. North America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.3.3. North America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.3.4. Psychiatric Digital Biomarkers Market - US
  - 8.3.4.1. US: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.3.4.2. US: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.3.4.3. US: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.3.5. Psychiatric Digital Biomarkers Market - Canada
  - 8.3.5.1. Canada: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
8.4. Psychiatric Digital Biomarkers Market - Europe
- 8.4.1. Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.4.3. Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.4. Psychiatric Digital Biomarkers Market - UK
  - 8.4.4.1. UK: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.5. Psychiatric Digital Biomarkers Market - France
  - 8.4.5.1. France: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.4.5.2. France: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.4.5.3. France: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.6. Psychiatric Digital Biomarkers Market - Germany
  - 8.4.6.1. Germany: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.7. Psychiatric Digital Biomarkers Market - Italy
  - 8.4.7.1. Italy: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.8. Psychiatric Digital Biomarkers Market - Spain
  - 8.4.8.1. Spain: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.9. Psychiatric Digital Biomarkers Market - Netherlands
  - 8.4.9.1. Netherlands: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.10. Psychiatric Digital Biomarkers Market - Russia
  - 8.4.10.1. Russia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.4.11. Psychiatric Digital Biomarkers Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
8.5. Psychiatric Digital Biomarkers Market - Asia Pacific
- 8.5.1. Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.4. Psychiatric Digital Biomarkers Market - China
  - 8.5.4.1. China: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.5.4.2. China: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.5.4.3. China: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.5. Psychiatric Digital Biomarkers Market - India
  - 8.5.5.1. India: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.5.5.2. India: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.5.5.3. India: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.6. Psychiatric Digital Biomarkers Market - Malaysia
  - 8.5.6.1. Malaysia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.7. Psychiatric Digital Biomarkers Market - Japan
  - 8.5.7.1. Japan: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.8. Psychiatric Digital Biomarkers Market - Indonesia
  - 8.5.8.1. Indonesia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.9. Psychiatric Digital Biomarkers Market - South Korea
  - 8.5.9.1. South Korea: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.10. Psychiatric Digital Biomarkers Market - Australia
  - 8.5.10.1. Australia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.5.11. Psychiatric Digital Biomarkers Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
8.6. Psychiatric Digital Biomarkers Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.4. Psychiatric Digital Biomarkers Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.5. Psychiatric Digital Biomarkers Market - UAE
  - 8.6.5.1. UAE: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.6. Psychiatric Digital Biomarkers Market - Israel
  - 8.6.6.1. Israel: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.7. Psychiatric Digital Biomarkers Market - South Africa
  - 8.6.7.1. South Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.6.8. Psychiatric Digital Biomarkers Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
8.7. Psychiatric Digital Biomarkers Market - Latin America
- 8.7.1. Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
- 8.7.3. Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.7.4. Psychiatric Digital Biomarkers Market - Mexico
  - 8.7.4.1. Mexico: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.7.5. Psychiatric Digital Biomarkers Market - Brazil
  - 8.7.5.1. Brazil: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.7.6. Psychiatric Digital Biomarkers Market - Argentina
  - 8.7.6.1. Argentina: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)
- 8.7.7. Psychiatric Digital Biomarkers Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Type, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Psychiatric Digital Biomarkers Market, by Clinical Practice, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Psychiatric Digital Biomarkers Market, by End Use, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Biogen
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Brainomix
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Clario
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Empatica Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Huma
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. IXICO plc
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Koneksa Health
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. PureTech Health PLC
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Sonde Health, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. VivoSense
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Xiamen AJK Technology Co., Ltd.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development